Literature DB >> 11746520

Cellular and molecular properties associated with osteosarcoma cells.

D Benayahu1, I Shur, R Marom, I Meller, J Issakov.   

Abstract

Osteosarcoma cells are recognized by abnormal function that causes a primary bone tumor. Osteosarcoma cells U(2)OS and SAOS-2 were analyzed for the expression of cell surface markers. High expression was quantified for hyaloronidase receptor (CD-44) > moderate for integrins (CD-51 and -61), > and lower for selectins (CD-62). High mitotic capacity were demonstrated by gene expression (measured by RT-PCR) and the protein level (measured by FACS) for cFOS, cMYC, and cJUN. The basic definition of osteosarcoma is excessive production of pathological osteoid. Expression of mRNA for matrix genes osteocalcin, osteonectin, and biglycan was studied. Osteocalcin and osteonectin were detected in RNA from primary cultured marrow stromal, trabecular bone cells, and osteosarcoma cell lines (U(2)OS, SAOS-2). mRNA for biglycan was detected only in primary cells and MG-63 cell line and was undetectable in RNA from U(2)OS, SAOS-2 osteosarcoma cell lines and by RNA extracted from bone biopsies of osteosarcoma patients. The absence of biglycan message observed in osteosarcoma samples provides evidence for the alterations in the extra cellular matrix which result with non-mineralized osteoid produced by the osteosarcoma cells. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11746520     DOI: 10.1002/jcb.1270

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  18 in total

Review 1.  The biology of small leucine-rich proteoglycans in bone pathophysiology.

Authors:  Dragana Nikitovic; John Aggelidakis; Marian F Young; Renato V Iozzo; Nikos K Karamanos; George N Tzanakakis
Journal:  J Biol Chem       Date:  2012-08-09       Impact factor: 5.157

2.  Biomolecular analysis of matrix proteoglycans as biomarkers in non small cell lung cancer.

Authors:  Maristela P Rangel; Vanessa K de Sá; Tabatha Prieto; João Roberto M Martins; Eloísa R Olivieri; Dirce Carraro; Teresa Takagaki; Vera Luiza Capelozzi
Journal:  Glycoconj J       Date:  2018-03-03       Impact factor: 2.916

3.  HER-2/neu-mediated down-regulation of biglycan associated with altered growth properties.

Authors:  Christian V Recktenwald; Sandra Leisz; André Steven; Kousaku Mimura; Anja Müller; Jens Wulfänger; Rolf Kiessling; Barbara Seliger
Journal:  J Biol Chem       Date:  2012-05-11       Impact factor: 5.157

4.  Identification of novel candidate oncogenes in chromosome region 17p11.2-p12 in human osteosarcoma.

Authors:  Joeri Both; Thijs Wu; Johannes Bras; Gerard R Schaap; Frank Baas; Theo J M Hulsebos
Journal:  PLoS One       Date:  2012-01-26       Impact factor: 3.240

5.  GRM4 gene polymorphism is associated with susceptibility and prognosis of osteosarcoma in a Chinese Han population.

Authors:  Chaoyin Jiang; Hua Chen; Lei Shao; Yang Dong
Journal:  Med Oncol       Date:  2014-07       Impact factor: 3.064

6.  Focal chromosomal copy number aberrations identify CMTM8 and GPR177 as new candidate driver genes in osteosarcoma.

Authors:  Joeri Both; Oscar Krijgsman; Johannes Bras; Gerard R Schaap; Frank Baas; Bauke Ylstra; Theo J M Hulsebos
Journal:  PLoS One       Date:  2014-12-31       Impact factor: 3.240

7.  Heterogeneity of osteosarcoma cell lines led to variable responses in reprogramming.

Authors:  Pei Feng Choong; Hui Xin Teh; Hoon Koon Teoh; Han Kiat Ong; Kong Bung Choo; Shigeki Sugii; Soon Keng Cheong; Tunku Kamarul
Journal:  Int J Med Sci       Date:  2014-08-22       Impact factor: 3.738

8.  Silencing of Ether à go-go 1 by shRNA inhibits osteosarcoma growth and cell cycle progression.

Authors:  Jin Wu; Daixing Zhong; Xijin Fu; Qingjun Liu; Liangqi Kang; Zhenqi Ding
Journal:  Int J Mol Sci       Date:  2014-04-01       Impact factor: 5.923

9.  Down-regulation of tumor endothelial marker 8 suppresses cell proliferation mediated by ERK1/2 activity.

Authors:  Chuangjie Cao; Zhuo Wang; Leilei Huang; Lihong Bai; Yuefeng Wang; Yingjie Liang; Chengyun Dou; Liantang Wang
Journal:  Sci Rep       Date:  2016-03-21       Impact factor: 4.379

10.  Silencing of hERG1 Gene Inhibits Proliferation and Invasion, and Induces Apoptosis in Human Osteosarcoma Cells by Targeting the NF-κB Pathway.

Authors:  Wenrong Zeng; Qingjun Liu; Zhida Chen; Xinyu Wu; Yuanfu Zhong; Jin Wu
Journal:  J Cancer       Date:  2016-04-10       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.